Signaling pathway switch in breast cancer. - Inserm - Institut national de la santé et de la recherche médicale Access content directly
Journal Articles Cancer Cell International Year : 2013

Signaling pathway switch in breast cancer.


Next generation sequencing studies have drawn the general landscape of breast cancers and identified hundreds of new, actual therapeutic targets. Two major signaling pathways seem to be altered in a vast proportion of breast cancers. The PI3 kinase/AKT pathway is activated and the JUN/MAPK pathway is repressed. Via the regulation of the cell cycle this metabolic switch impacts on the balance between self-renewal, proliferation and differentiation of the tumor-initiating cells.
Fichier principal
Vignette du fichier
1475-2867-13-66.pdf (589.58 Ko) Télécharger le fichier
1475-2867-13-66.xml (23.3 Ko) Télécharger le fichier
Origin : Publisher files allowed on an open archive
Format : Other

Dates and versions

inserm-00844782 , version 1 (15-07-2013)



Arnaud Guille, Max Chaffanet, Daniel Birnbaum. Signaling pathway switch in breast cancer.. Cancer Cell International, 2013, 13 (1), pp.66. ⟨10.1186/1475-2867-13-66⟩. ⟨inserm-00844782⟩
141 View
210 Download



Gmail Facebook X LinkedIn More